aluates Reports

$ 0.0

Automative

Global Cachexia Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-5U5939

Global Cachexia Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Cachexia Treatment Market Research Report 2025

Code: QYRE-Auto-5U5939

Report

June 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alder Biopharmaceuticals Inc.

GTx Inc.

Helsinn Group

Merck& Co. Inc

Bristol Myers Squibb Company

Helsinn Healthcare S.A.

PsiOxus

Purdue Pharma L.P

Eterna Zentaris Inc.

Aphios Corporation

Neurim

Novartis

Skyepharma

Cachexia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cachexia Treatment Market

The global market for Cachexia Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cachexia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cachexia Treatment.

The Cachexia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cachexia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cachexia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cachexia Treatment Market Report

Report Metric	Details
Report Name	Cachexia Treatment Market
CAGR	5%
Segment by Type	Weight Loss Stabilizers Appetite Stimulants Progestogens Corticosteroids Combination therapies Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Drug Stores Online
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc., Bristol-Myers Squibb Company, Helsinn Healthcare S.A., PsiOxus, Purdue Pharma L.P., Eterna Zentaris Inc., Aphios Corporation, Neurim, Novartis AG, SkyePharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cachexia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cachexia Treatment Market report?

Ans: The main players in the Cachexia Treatment Market are Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc., Bristol-Myers Squibb Company, Helsinn Healthcare S.A., PsiOxus, Purdue Pharma L.P., Eterna Zentaris Inc., Aphios Corporation, Neurim, Novartis AG, SkyePharma

What are the Application segmentation covered in the Cachexia Treatment Market report?

Ans: The Applications covered in the Cachexia Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online

What are the Type segmentation covered in the Cachexia Treatment Market report?

Ans: The Types covered in the Cachexia Treatment Market report are Weight Loss Stabilizers, Appetite Stimulants, Progestogens, Corticosteroids, Combination therapies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Weight Loss Stabilizers

1.2.3 Appetite Stimulants

1.2.4 Progestogens

1.2.5 Corticosteroids

1.2.6 Combination therapies

1.2.7 Others

1.3 Market by Application

1.3.1 Global Cachexia Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Drug Stores

1.3.5 Online

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cachexia Treatment Market Perspective (2020-2031)

2.2 Global Cachexia Treatment Growth Trends by Region

2.2.1 Global Cachexia Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cachexia Treatment Historic Market Size by Region (2020-2025)

2.2.3 Cachexia Treatment Forecasted Market Size by Region (2026-2031)

2.3 Cachexia Treatment Market Dynamics

2.3.1 Cachexia Treatment Industry Trends

2.3.2 Cachexia Treatment Market Drivers

2.3.3 Cachexia Treatment Market Challenges

2.3.4 Cachexia Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cachexia Treatment Players by Revenue

3.1.1 Global Top Cachexia Treatment Players by Revenue (2020-2025)

3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cachexia Treatment Revenue

3.4 Global Cachexia Treatment Market Concentration Ratio

3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2024

3.5 Global Key Players of Cachexia Treatment Head office and Area Served

3.6 Global Key Players of Cachexia Treatment, Product and Application

3.7 Global Key Players of Cachexia Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cachexia Treatment Breakdown Data by Type

4.1 Global Cachexia Treatment Historic Market Size by Type (2020-2025)

4.2 Global Cachexia Treatment Forecasted Market Size by Type (2026-2031)

5 Cachexia Treatment Breakdown Data by Application

5.1 Global Cachexia Treatment Historic Market Size by Application (2020-2025)

5.2 Global Cachexia Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cachexia Treatment Market Size (2020-2031)

6.2 North America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cachexia Treatment Market Size by Country (2020-2025)

6.4 North America Cachexia Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cachexia Treatment Market Size (2020-2031)

7.2 Europe Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cachexia Treatment Market Size by Country (2020-2025)

7.4 Europe Cachexia Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cachexia Treatment Market Size (2020-2031)

8.2 Asia-Pacific Cachexia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cachexia Treatment Market Size (2020-2031)

9.2 Latin America Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cachexia Treatment Market Size by Country (2020-2025)

9.4 Latin America Cachexia Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cachexia Treatment Market Size (2020-2031)

10.2 Middle East & Africa Cachexia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alder Biopharmaceuticals Inc.

11.1.1 Alder Biopharmaceuticals Inc. Company Details

11.1.2 Alder Biopharmaceuticals Inc. Business Overview

11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction

11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025)

11.1.5 Alder Biopharmaceuticals Inc. Recent Development

11.2 GTx Inc.

11.2.1 GTx Inc. Company Details

11.2.2 GTx Inc. Business Overview

11.2.3 GTx Inc. Cachexia Treatment Introduction

11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2020-2025)

11.2.5 GTx Inc. Recent Development

11.3 Helsinn Group

11.3.1 Helsinn Group Company Details

11.3.2 Helsinn Group Business Overview

11.3.3 Helsinn Group Cachexia Treatment Introduction

11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2020-2025)

11.3.5 Helsinn Group Recent Development

11.4 Merck & Co. Inc.

11.4.1 Merck & Co. Inc. Company Details

11.4.2 Merck & Co. Inc. Business Overview

11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction

11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025)

11.4.5 Merck & Co. Inc. Recent Development

11.5 Bristol-Myers Squibb Company

11.5.1 Bristol-Myers Squibb Company Company Details

11.5.2 Bristol-Myers Squibb Company Business Overview

11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction

11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025)

11.5.5 Bristol-Myers Squibb Company Recent Development

11.6 Helsinn Healthcare S.A.

11.6.1 Helsinn Healthcare S.A. Company Details

11.6.2 Helsinn Healthcare S.A. Business Overview

11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction

11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025)

11.6.5 Helsinn Healthcare S.A. Recent Development

11.7 PsiOxus

11.7.1 PsiOxus Company Details

11.7.2 PsiOxus Business Overview

11.7.3 PsiOxus Cachexia Treatment Introduction

11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2020-2025)

11.7.5 PsiOxus Recent Development

11.8 Purdue Pharma L.P.

11.8.1 Purdue Pharma L.P. Company Details

11.8.2 Purdue Pharma L.P. Business Overview

11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction

11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025)

11.8.5 Purdue Pharma L.P. Recent Development

11.9 Eterna Zentaris Inc.

11.9.1 Eterna Zentaris Inc. Company Details

11.9.2 Eterna Zentaris Inc. Business Overview

11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction

11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025)

11.9.5 Eterna Zentaris Inc. Recent Development

11.10 Aphios Corporation

11.10.1 Aphios Corporation Company Details

11.10.2 Aphios Corporation Business Overview

11.10.3 Aphios Corporation Cachexia Treatment Introduction

11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025)

11.10.5 Aphios Corporation Recent Development

11.11 Neurim

11.11.1 Neurim Company Details

11.11.2 Neurim Business Overview

11.11.3 Neurim Cachexia Treatment Introduction

11.11.4 Neurim Revenue in Cachexia Treatment Business (2020-2025)

11.11.5 Neurim Recent Development

11.12 Novartis AG

11.12.1 Novartis AG Company Details

11.12.2 Novartis AG Business Overview

11.12.3 Novartis AG Cachexia Treatment Introduction

11.12.4 Novartis AG Revenue in Cachexia Treatment Business (2020-2025)

11.12.5 Novartis AG Recent Development

11.13 SkyePharma

11.13.1 SkyePharma Company Details

11.13.2 SkyePharma Business Overview

11.13.3 SkyePharma Cachexia Treatment Introduction

11.13.4 SkyePharma Revenue in Cachexia Treatment Business (2020-2025)

11.13.5 SkyePharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alder Biopharmaceuticals Inc.

GTx Inc.

Helsinn Group

Merck& Co. Inc

Bristol Myers Squibb Company

Helsinn Healthcare S.A.

PsiOxus

Purdue Pharma L.P

Eterna Zentaris Inc.

Aphios Corporation

Neurim

Novartis

Skyepharma

List of Tables

Table 1. Global Cachexia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Weight Loss Stabilizers

Table 3. Key Players of Appetite Stimulants

Table 4. Key Players of Progestogens

Table 5. Key Players of Corticosteroids

Table 6. Key Players of Combination therapies

Table 7. Key Players of Others

Table 8. Global Cachexia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Cachexia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Cachexia Treatment Market Share by Region (2020-2025)

Table 12. Global Cachexia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Cachexia Treatment Market Share by Region (2026-2031)

Table 14. Cachexia Treatment Market Trends

Table 15. Cachexia Treatment Market Drivers

Table 16. Cachexia Treatment Market Challenges

Table 17. Cachexia Treatment Market Restraints

Table 18. Global Cachexia Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Cachexia Treatment Market Share by Players (2020-2025)

Table 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)

Table 21. Ranking of Global Top Cachexia Treatment Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Cachexia Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Cachexia Treatment, Headquarters and Area Served

Table 24. Global Key Players of Cachexia Treatment, Product and Application

Table 25. Global Key Players of Cachexia Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Cachexia Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Cachexia Treatment Revenue Market Share by Type (2020-2025)

Table 29. Global Cachexia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Cachexia Treatment Revenue Market Share by Type (2026-2031)

Table 31. Global Cachexia Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Cachexia Treatment Revenue Market Share by Application (2020-2025)

Table 33. Global Cachexia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Cachexia Treatment Revenue Market Share by Application (2026-2031)

Table 35. North America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Cachexia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Cachexia Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Cachexia Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Cachexia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Cachexia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 50. Alder Biopharmaceuticals Inc. Company Details

Table 51. Alder Biopharmaceuticals Inc. Business Overview

Table 52. Alder Biopharmaceuticals Inc. Cachexia Treatment Product

Table 53. Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 54. Alder Biopharmaceuticals Inc. Recent Development

Table 55. GTx Inc. Company Details

Table 56. GTx Inc. Business Overview

Table 57. GTx Inc. Cachexia Treatment Product

Table 58. GTx Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 59. GTx Inc. Recent Development

Table 60. Helsinn Group Company Details

Table 61. Helsinn Group Business Overview

Table 62. Helsinn Group Cachexia Treatment Product

Table 63. Helsinn Group Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 64. Helsinn Group Recent Development

Table 65. Merck & Co. Inc. Company Details

Table 66. Merck & Co. Inc. Business Overview

Table 67. Merck & Co. Inc. Cachexia Treatment Product

Table 68. Merck & Co. Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 69. Merck & Co. Inc. Recent Development

Table 70. Bristol-Myers Squibb Company Company Details

Table 71. Bristol-Myers Squibb Company Business Overview

Table 72. Bristol-Myers Squibb Company Cachexia Treatment Product

Table 73. Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 74. Bristol-Myers Squibb Company Recent Development

Table 75. Helsinn Healthcare S.A. Company Details

Table 76. Helsinn Healthcare S.A. Business Overview

Table 77. Helsinn Healthcare S.A. Cachexia Treatment Product

Table 78. Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 79. Helsinn Healthcare S.A. Recent Development

Table 80. PsiOxus Company Details

Table 81. PsiOxus Business Overview

Table 82. PsiOxus Cachexia Treatment Product

Table 83. PsiOxus Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 84. PsiOxus Recent Development

Table 85. Purdue Pharma L.P. Company Details

Table 86. Purdue Pharma L.P. Business Overview

Table 87. Purdue Pharma L.P. Cachexia Treatment Product

Table 88. Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 89. Purdue Pharma L.P. Recent Development

Table 90. Eterna Zentaris Inc. Company Details

Table 91. Eterna Zentaris Inc. Business Overview

Table 92. Eterna Zentaris Inc. Cachexia Treatment Product

Table 93. Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 94. Eterna Zentaris Inc. Recent Development

Table 95. Aphios Corporation Company Details

Table 96. Aphios Corporation Business Overview

Table 97. Aphios Corporation Cachexia Treatment Product

Table 98. Aphios Corporation Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 99. Aphios Corporation Recent Development

Table 100. Neurim Company Details

Table 101. Neurim Business Overview

Table 102. Neurim Cachexia Treatment Product

Table 103. Neurim Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 104. Neurim Recent Development

Table 105. Novartis AG Company Details

Table 106. Novartis AG Business Overview

Table 107. Novartis AG Cachexia Treatment Product

Table 108. Novartis AG Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 109. Novartis AG Recent Development

Table 110. SkyePharma Company Details

Table 111. SkyePharma Business Overview

Table 112. SkyePharma Cachexia Treatment Product

Table 113. SkyePharma Revenue in Cachexia Treatment Business (2020-2025) & (US$ Million)

Table 114. SkyePharma Recent Development

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Authors List of This Report

List of Figures

Figure 1. Cachexia Treatment Picture

Figure 2. Global Cachexia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cachexia Treatment Market Share by Type: 2024 VS 2031

Figure 4. Weight Loss Stabilizers Features

Figure 5. Appetite Stimulants Features

Figure 6. Progestogens Features

Figure 7. Corticosteroids Features

Figure 8. Combination therapies Features

Figure 9. Others Features

Figure 10. Global Cachexia Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Cachexia Treatment Market Share by Application: 2024 VS 2031

Figure 12. Hospital Pharmacies Case Studies

Figure 13. Retail Pharmacies Case Studies

Figure 14. Drug Stores Case Studies

Figure 15. Online Case Studies

Figure 16. Cachexia Treatment Report Years Considered

Figure 17. Global Cachexia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Cachexia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Cachexia Treatment Market Share by Region: 2024 VS 2031

Figure 20. Global Cachexia Treatment Market Share by Players in 2024

Figure 21. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Cachexia Treatment Revenue in 2024

Figure 23. North America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Cachexia Treatment Market Share by Country (2020-2031)

Figure 25. United States Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Cachexia Treatment Market Share by Country (2020-2031)

Figure 29. Germany Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Cachexia Treatment Market Share by Region (2020-2031)

Figure 37. China Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Cachexia Treatment Market Share by Country (2020-2031)

Figure 45. Mexico Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Cachexia Treatment Market Share by Country (2020-2031)

Figure 49. Turkey Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Cachexia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Alder Biopharmaceuticals Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 53. GTx Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 54. Helsinn Group Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 55. Merck & Co. Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 57. Helsinn Healthcare S.A. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 58. PsiOxus Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 59. Purdue Pharma L.P. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 60. Eterna Zentaris Inc. Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 61. Aphios Corporation Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 62. Neurim Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 63. Novartis AG Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 64. SkyePharma Revenue Growth Rate in Cachexia Treatment Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anemia Treatment Market Research Report 2024

Global Appetite Control Suppressants Market Insights Forecast to 2030

Global Weight Loss Therapeutics Market Insights Forecast to 2030

Global Obesity Diagnosis and Treatment Market Research Report 2024

Global Bariatric Scales Market Research Report 2024

Global Bulimia Nervosa Treatment Market Research Report 2024

Global Weight loss Drugs Market Insights Forecast to 2030

Weight Loss and Weight Management Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anemia Treatment Drugs Market Insights Forecast to 2030

Global Syndrome Progressive Ataxia Weakness Disorder Treatment Market Research Report 2025

Global Sarcopenia Treatments Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Weight Loss and Weight Management Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Obesity Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Binge Eating Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Associated Lipodystrophy Syndrome Treatment Market Research Report 2024

Sarcopenia Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Weight Loss and Diet Management Market Research Report 2025

Global Weight Reduction Medicine Market Research Report 2024

Weight Loss and Weight Management Diets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions